Reversal of human neutrophil survival by leukotriene B4 receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 6, 1999, Pages 2079-2085

  Lee, Elaine ^a,b   Lindo, Trisha ^a,b   Jackson, Nicholas ^a,b   Meng Choong, Lee ^a,b   Reynolds, Paula ^a,b   Hill, Anthony ^a,b   Haswell, Malcolm ^a,b   Jackson, Stephen ^a,b   Kilfeather, Stephen ^a,b  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ARACHIDONATE 5 LIPOXYGENASE; DEXAMETHASONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; LIPOPOLYSACCHARIDE; LIPOXYGENASE INHIBITOR; N [3 (3 PHENOXYPHENYL)ALLYL]ACETOHYDROXAMIC ACID; POBILUKAST; SB 201146; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ASTHMA; CELL SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; NEUTROPHIL; NEUTROPHILIA; PRIORITY JOURNAL;

EID: 0033430377     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.6.9903136     Document Type: Article

References (28)

1. Martin, T. R., G. Raghu, R. J. Maunder, and S. C. Springmeyer. 1985. The effects of chronic-bronchitis and chronic air-flow obstruction on lung cell populations recovered by bronchoalveolar lavage. Am. Rev. Respir. Dis. 132:254-260.
2. Thompson, A. B., D. Daughton, R. A. Robbins, M. A. Ghafouri, M. Oehlerking, and S. I. Rennard. 1989. Intraluminal airway inflammation in chronic bronchitis - characterization and correlation with clinical parameters. Am. Rev. Respir. Dis. 140:1527-1537.
3. Claesson, H. E., B. Odlander, and P. J. Jakobsson. 1992. Leukotriene-B4 in the immune-system. Int. J. Immunopharmacol. 14:441-449.
4. Chancy, M. O., L. L. Froelich, D. M. Gapinski, B. E. Mallett, and W. T. Jackson. 1992. Characterization of the spatial arrangement of the 2 acid-binding sites on the human neutrophil ltb(4) receptor. Receptor 2:169-179.
5. Crooks, S. W., and R. A. Stockley. 1998. Leukotriene B4. Int. J. Biochem. Cell Biol. 30:173-178.
6. Sweeney, J. F., P. K. Nguyen, G. M. Omann, and D. B. Hinshaw. 1998. Lipopolysaccharide protects polymorphonuclear leukocytes from apoptosis via tyrosine phosphorylation-dependent signal transduction pathways. J. Surg. Res. 74:64-70.
7. Condliffe, A. M., E. Kitchen, and E. R. Chilvers. 1998. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin. Sci. 94:461-471.
8. Wei, S., J. H. Liu, P. K. EplingBurnette, A. M. Gamero, D. Ussery, E. W. Pearson, M. E. Elkabani, J. I. Diaz, and J. Y. Djeu. 1996. Critical role of Lyn kinase in inhibition of neutrophil apoptosis by granulocytemacrophage colony-stimulating factor. J. Immunol. 157:5155-5162.
9. Walsh, G. M., and A. J. Wardlaw. 1997. Dexamethasone inhibits prolonged survival and autocrine granulocyte-macrophage colony-stimulating factor production by human cosinophils cultured on laminin or tissue fibronectin. J. Allergy Clin. Immunol. 100:208-215.
10. Cox, G., and R. C. Austin. 1997. Dexamethasone-induced suppression of apoptosis in human neutrophils requires continuous stimulation of new protein synthesis. J. Leukoc. Biol 61:224-230.
11. Krump, E., and P. Borgeat. 1994. Kinetics of 5-lipoxygenase activation, arachidonic-acid release, and leukotriene synthesis in human neutrophils - effects of granulocyte-macrophage colony-stimulating factor. Biochim. Biophys. Acta (Lipids Lipid Metab.) 1213:135-139.
12. Conklyn, M. J., R. B. Alpert, K. F. Wright, and H. J. Showell. 1997. Inhibition of spontaneous apoptosis in neutrophils by 5-lipoxygenase metabolites of arachidonic acid: potential involvement of the low affinity LTB4 receptor. J. Leukoc. Biol. 55:13.
13. Denburg, J. A. 1995. Microenvironmental influences on inflammatory cell differentiation. Allergy 50:25-28.
14. Rivas, C. I., J. C. Vera, F. DelgadoLopez, M. L. Heaney, V. H. Guaiquil, R. H. Zhang, H. I. Scher, I. I. Concha, F. Nualart, C. Cordon Cardo, and D. W. Golde. 1998. Expression of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancer. Blood 91: 1037-1043.
15. Krump, E., S. Boudreault, M. E. Surette, and P. Borgeat. 1997. Effect of GM-CSF on leukotriene B4 synthesis in human neutrophils: facilitation of the priming effect by autologous plasma. Adv. Exp. Med. Biol. 400:583-587.
16. Wildfeuer, A., I. S. Neu, H. Safayhi, G. Metzger, M. Wehrmann, U. Vogel, and H. P. T. Ammon. 1998. Effects of boswellic acids extracted from a herbal medicine on the biosynthesis of leukotrienes and the course of experimental autoimmune encephalomyelitis. Arzneimittelforschung (Drug Res.) 48:668-674.
17. Linden, M. 1992. The effects of beta-2-adrenoceptor agonists and a corticosteroid, budesonide, on the secretion of inflammatory mediators from monocytes. Br. J. Pharmacol. 107:156-160.
18. Spaethe, S. M., D. W. Snyder, P. A. Pechous, T. Clarke, and E. L. Vanalstyne. 1992. Guinea-pig whole-blood 5-lipoxygenase assay-utility in the assessment of potential 5-lipoxygenase inhibitors. Biochem. Pharmacol. 43:377-382.
19. Daines, R. A., P. A. Chambers, J. J. Foley, D. E. Griswold, W. D. Kingsbury, L. D. Martin, D. B. Schmidt, K. K. C. Sham, and H. M. Sarau. 1996. (E)-3-[6-[[(2,6-dichlorophenyl)thiolmethyl]-3-(2-phenylethoxy)-2-pyridin yl]-2-propenoic acid: a high-affinity leukotriene B-4 receptor antagonist with oral antiinflammatory activity. J. Med. Chem. 39:3837-3841.
20. Bouchelouche, P. N., and D. Berild. 1991. Possible existence of leukotriene-D4 receptors and mechanism of their signal transduction in human polymorphonuclear leukocytes. Scandi. J. Clin. Lab. Invest. 51: 47-55.
21. Hebert, M. J., T. Takano, H. Holthofer, and H. R. Brady. 1996. Sequential morphologic events during apoptosis of human neutrophils - modulation by lipoxygenase-derived eicosanoids. J. Immunol. 157: 3105-3115.
22. Tang, D. G., Y. Q. Chen, and K. V. Honn. 1996. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc. Natl. Acad Sci. U.S.A. 93:5241-5246.
23. Lee, E., K. Ryan, N. Jackson, M. Haswell, L. Robertson, A. A. Hill, and S. A. Kilfeather. 1998. Leukotriene-B4 (LTB4) mediates LPS and GM-CSF-induced neutrophil survival: reversal by LTB4 receptor blockade (abstract). Am. J. Respir. Crit. Care Med. 157:A142
24. Hart, S. P., C. Haslett, and L Dransfield. 1996. Recognition of apoptotic cells by phagocytes. Experientia 52:950-956.
25. Murphy, J. F., J. L. Mcgregor, and L. L. K. Leung. 1996. Senescent human neutrophil binding to thrombospondin (tsp) - evidence for a tsp-independent pathway of phagocytosis by macrophages. Blood 88:612.
26. Lee, E., N. Jackson, A. A. Hill, and S. A. Kilfeather. 1998. Cysteinyl leukolriene (LTC4 and D4) mediation of GM-CSF-induced eosinophil survival: reversal by Cysteinyl leukotriene receptor antagonism. Eur. Respir. J. 12:360s.
27. Evans, D. J., P. J. Barnes, S. M. Spaethe, E. L. Vanalstyne, M. I. Mitchell, and B. J. C'Connor. 1996. Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma. Thorax 51:1178-1184.
28. Mcevoy, C. E., and D. E. Nicwoehner. 1997. Adverse effects of corticosteroid therapy for COPD - a critical review. Chest 111:732-743.